EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Modeling of Respiratory Diseases Evolving with Fibrosis from Organoids Derived from Human Pluripotent Stem Cells

Irene Chamorro-Herrero iD, Alberto Zambrano iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24054413 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Irene Chamorro-Herrero und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Biotechnology of Stem Cells and Organoids, Chronic Diseases Program, Instituto de Salud Carlos III, 28220 Madrid, Spain. Hauptthemen laut MEDLINE: COVID-19, Cystic Fibrosis, Pluripotent Stem Cells, Pulmonary Disease, Chronic Obstructive. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 150 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Respiratory disease is one of the leading causes of morbidity and mortality worldwide. There is no cure for most diseases, which are treated symptomatically. Hence, new strategies are required to deepen the understanding of the disease and development of therapeutic strategies. The advent of stem cell and organoid technology has enabled the development of human pluripotent stem cell lines and adequate differentiation protocols for developing both airways and lung organoids in different formats. These novel human-pluripotent-stem-cell-derived organoids have enabled relatively accurate disease modeling. Idiopathic pulmonary fibrosis is a fatal and debilitating disease that exhibits prototypical fibrotic features that may be, to some extent, extrapolated to other conditions. Thus, respiratory diseases such as cystic fibrosis, chronic obstructive pulmonary disease, or the one caused by SARS-CoV-2 may reflect some fibrotic aspects reminiscent of those present in idiopathic pulmonary fibrosis. Modeling of fibrosis of the airways and the lung is a real challenge due to the large number of epithelial cells involved and interaction with other cell types of mesenchymal origin. This review will focus on the status of respiratory disease modeling from human-pluripotent-stem-cell-derived organoids, which are being used to model several representative respiratory diseases, such as idiopathic pulmonary fibrosis, cystic fibrosis, chronic obstructive pulmonary disease, and COVID-19.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Cystic FibrosisPluripotent Stem CellsPulmonary Disease, Chronic ObstructiveRespiration DisordersIdiopathic Pulmonary FibrosisHumansSARS-CoV-2FibrosisOrganoids

Stichwörter der Autor:innen

CFCOPDCOVID-19IPFSARS-CoV-2chronic obstructive pulmonary diseasecystic fibrosisdisease modelingfibrosisidiopathic pulmonary fibrosisminilungsmyofibroblastspluripotent stem cells

Autor:innen und Institutionen

  • Laboratory of Biotechnology of Stem Cells and Organoids, Chronic Diseases Program, Instituto de Salud Carlos III, 28220 Madrid, Spain.

ORCID-Profile: Irene Chamorro-Herrero, Alberto Zambrano

Förderung

  • Instituto de Salud Carlos III

Zitieren

APA

Chamorro-Herrero, I., & Zambrano, A. (2023). Modeling of Respiratory Diseases Evolving with Fibrosis from Organoids Derived from Human Pluripotent Stem Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24054413

Vancouver

Chamorro-Herrero I, Zambrano A. Modeling of Respiratory Diseases Evolving with Fibrosis from Organoids Derived from Human Pluripotent Stem Cells. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24054413

BibTeX
@article{ChamorroHerrero2023,
  author = {Chamorro-Herrero, Irene and Zambrano, Alberto},
  title = {Modeling of Respiratory Diseases Evolving with Fibrosis from Organoids Derived from Human Pluripotent Stem Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24054413}
}
Kostenlos starten →